Axsome Therapeutics (NASDAQ:AXSM) Given “Outperform” Rating at William Blair
William Blair restated their outperform rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a report released on Tuesday,RTT News reports. Other equities research analysts have also recently issued reports about the company. Bank of America lifted their price objective on Axsome Therapeutics from $143.00 to $167.00 and gave the stock a “buy” […]
William Blair restated their outperform rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a report released on Tuesday,RTT News reports. Other equities research analysts have also recently issued reports about the company. Bank of America lifted their price objective on Axsome Therapeutics from $143.00 to $167.00 and gave the stock a “buy” […]
